$BMY

AI 分析

生成於 May 11, 2026

AI Score
66/ 100
Hold$BMY

Bristol-Myers Squibb

$BMYNYSEHealthcareLarge-Cap

Bristol-Myers Squibb discovers, develops, and delivers innovative medicines for serious diseases including cancer, cardiovascular, and immunology.

Market Cap
$100.0B
Revenue (TTM)
$45.0B
+3.0%
Net Income (TTM)
$8.0B
-5.0%
EPS (TTM)
$3.85
P/E Ratio
12.0
Dividend Yield
4.5%
52-Week Range
$40-$58
Beta
0.52
Dimension Scores
Fundamental
68
Technical
60
Sentiment
64
Risk / Reward
72
Momentum
54
FundTechSentRiskMome
Financial Health
Profitability
73moderate
Growth
57moderate
Liquidity
80strong
Solvency
70strong
Efficiency
66strong

Valuation, technical analysis, investment thesis, risk assessment and more for $BMY

Free · No credit card required

免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。

探索更多

用 AI 分析任意股票

獲取涵蓋基本面、技術面、情緒面、風險評估和投資論點的結構化研究報告——約 60 秒完成。